CN105287613A - 一种复方芬苯达唑片剂的制备方法 - Google Patents
一种复方芬苯达唑片剂的制备方法 Download PDFInfo
- Publication number
- CN105287613A CN105287613A CN201510654814.1A CN201510654814A CN105287613A CN 105287613 A CN105287613 A CN 105287613A CN 201510654814 A CN201510654814 A CN 201510654814A CN 105287613 A CN105287613 A CN 105287613A
- Authority
- CN
- China
- Prior art keywords
- tablet
- fenbendazole
- group
- ivermectin
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IRHZVMHXVHSMKB-UHFFFAOYSA-N fenbendazole Chemical compound [CH]1C2=NC(NC(=O)OC)=NC2=CC=C1SC1=CC=CC=C1 IRHZVMHXVHSMKB-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 229960005473 fenbendazole Drugs 0.000 title claims abstract description 50
- 150000001875 compounds Chemical class 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000008187 granular material Substances 0.000 claims abstract description 36
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims abstract description 29
- 229960002418 ivermectin Drugs 0.000 claims abstract description 29
- 229920000159 gelatin Polymers 0.000 claims abstract description 25
- 235000019322 gelatine Nutrition 0.000 claims abstract description 25
- 108010010803 Gelatin Proteins 0.000 claims abstract description 15
- 239000008273 gelatin Substances 0.000 claims abstract description 15
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 229920003023 plastic Polymers 0.000 claims abstract description 6
- 239000004033 plastic Substances 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 25
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 claims description 19
- 229960002957 praziquantel Drugs 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 15
- 239000011812 mixed powder Substances 0.000 claims description 15
- 239000001828 Gelatine Substances 0.000 claims description 10
- 229920002472 Starch Polymers 0.000 claims description 10
- 239000007779 soft material Substances 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 239000008107 starch Substances 0.000 claims description 10
- 235000019698 starch Nutrition 0.000 claims description 10
- 239000011230 binding agent Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000000945 filler Substances 0.000 claims description 9
- 108010011485 Aspartame Proteins 0.000 claims description 8
- 239000000605 aspartame Substances 0.000 claims description 8
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 8
- 229960003438 aspartame Drugs 0.000 claims description 8
- 235000010357 aspartame Nutrition 0.000 claims description 8
- 239000000314 lubricant Substances 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 239000000741 silica gel Substances 0.000 claims description 7
- 229910002027 silica gel Inorganic materials 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 241000282472 Canis lupus familiaris Species 0.000 abstract description 48
- 239000003814 drug Substances 0.000 abstract description 39
- 230000000694 effects Effects 0.000 abstract description 24
- 229940079593 drug Drugs 0.000 abstract description 16
- 230000002147 killing effect Effects 0.000 abstract description 8
- 238000005286 illumination Methods 0.000 abstract description 7
- 238000007689 inspection Methods 0.000 abstract description 7
- 230000003247 decreasing effect Effects 0.000 abstract description 5
- 238000004090 dissolution Methods 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 4
- 238000004806 packaging method and process Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000007781 pre-processing Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 53
- 230000000507 anthelmentic effect Effects 0.000 description 22
- 210000003608 fece Anatomy 0.000 description 22
- 102000002322 Egg Proteins Human genes 0.000 description 18
- 108010000912 Egg Proteins Proteins 0.000 description 18
- 235000013601 eggs Nutrition 0.000 description 18
- 210000004681 ovum Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 238000010171 animal model Methods 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000002349 favourable effect Effects 0.000 description 5
- 241000282326 Felis catus Species 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 230000001846 repelling effect Effects 0.000 description 4
- 208000030852 Parasitic disease Diseases 0.000 description 3
- 238000009534 blood test Methods 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 241000238421 Arthropoda Species 0.000 description 2
- 241000244186 Ascaris Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000464908 Elliptica Species 0.000 description 2
- HMCCXLBXIJMERM-UHFFFAOYSA-N Febantel Chemical compound C1=C(NC(NC(=O)OC)=NC(=O)OC)C(NC(=O)COC)=CC(SC=2C=CC=CC=2)=C1 HMCCXLBXIJMERM-UHFFFAOYSA-N 0.000 description 2
- 206010061201 Helminthic infection Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000002163 Mesapamea fractilinea Species 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 241000244155 Taenia Species 0.000 description 2
- 241000244030 Toxocara canis Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000002141 anti-parasite Effects 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 244000079386 endoparasite Species 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 229960005282 febantel Drugs 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 238000012372 quality testing Methods 0.000 description 2
- 230000036391 respiratory frequency Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 208000004441 taeniasis Diseases 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- 241000754688 Cercaria Species 0.000 description 1
- 241000040710 Chela Species 0.000 description 1
- 206010009344 Clonorchiasis Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 208000020693 Demodicidosis Diseases 0.000 description 1
- 206010059410 Faecaluria Diseases 0.000 description 1
- 241000239183 Filaria Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- AQXXZDYPVDOQEE-MXDQRGINSA-N Pyrantel pamoate Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1.C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 AQXXZDYPVDOQEE-MXDQRGINSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000004188 Tooth Wear Diseases 0.000 description 1
- 241000242541 Trematoda Species 0.000 description 1
- 241000197881 Trichocephalus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- -1 benzene thibenzazoline class Chemical class 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 244000078703 ectoparasite Species 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 206010033794 paragonimiasis Diseases 0.000 description 1
- 230000000590 parasiticidal effect Effects 0.000 description 1
- 239000002297 parasiticide Substances 0.000 description 1
- 229940119022 praziquantel 23 mg Drugs 0.000 description 1
- 229940110524 praziquantel 30 mg Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960000996 pyrantel pamoate Drugs 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510654814.1A CN105287613B (zh) | 2015-10-12 | 2015-10-12 | 一种复方芬苯达唑片剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510654814.1A CN105287613B (zh) | 2015-10-12 | 2015-10-12 | 一种复方芬苯达唑片剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105287613A true CN105287613A (zh) | 2016-02-03 |
CN105287613B CN105287613B (zh) | 2019-04-09 |
Family
ID=55185901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510654814.1A Active - Reinstated CN105287613B (zh) | 2015-10-12 | 2015-10-12 | 一种复方芬苯达唑片剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105287613B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105853454A (zh) * | 2016-05-11 | 2016-08-17 | 高艳春 | 一种广谱抗寄生虫药纳米乳剂及其制备方法 |
CN107669646A (zh) * | 2017-10-31 | 2018-02-09 | 佛山市南海东方澳龙制药有限公司 | 伊维菌素片剂及其制备方法 |
CN107837238A (zh) * | 2017-10-31 | 2018-03-27 | 佛山市南海东方澳龙制药有限公司 | 伊维菌素片剂的制备方法及伊维菌素片剂 |
CN108079006A (zh) * | 2018-01-31 | 2018-05-29 | 佛山市南海东方澳龙制药有限公司 | 伊维菌素制剂的制备方法及伊维菌素制剂 |
CN109394713A (zh) * | 2018-12-26 | 2019-03-01 | 湖北中博绿亚生物技术有限公司 | 复方芬苯达唑噻嘧啶及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101966197A (zh) * | 2010-07-26 | 2011-02-09 | 天津生机集团股份有限公司 | 用于治疗牛严重复合型寄生虫感染的组合物及制备方法 |
CN103933045A (zh) * | 2014-05-14 | 2014-07-23 | 深圳市红瑞生物科技有限公司 | 驱虫药物及其制备方法 |
-
2015
- 2015-10-12 CN CN201510654814.1A patent/CN105287613B/zh active Active - Reinstated
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101966197A (zh) * | 2010-07-26 | 2011-02-09 | 天津生机集团股份有限公司 | 用于治疗牛严重复合型寄生虫感染的组合物及制备方法 |
CN103933045A (zh) * | 2014-05-14 | 2014-07-23 | 深圳市红瑞生物科技有限公司 | 驱虫药物及其制备方法 |
Non-Patent Citations (1)
Title |
---|
才学鹏等: "兽用长效驱虫制剂的研究进展及应用", 《中国兽医科学》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105853454A (zh) * | 2016-05-11 | 2016-08-17 | 高艳春 | 一种广谱抗寄生虫药纳米乳剂及其制备方法 |
CN107669646A (zh) * | 2017-10-31 | 2018-02-09 | 佛山市南海东方澳龙制药有限公司 | 伊维菌素片剂及其制备方法 |
CN107837238A (zh) * | 2017-10-31 | 2018-03-27 | 佛山市南海东方澳龙制药有限公司 | 伊维菌素片剂的制备方法及伊维菌素片剂 |
CN108079006A (zh) * | 2018-01-31 | 2018-05-29 | 佛山市南海东方澳龙制药有限公司 | 伊维菌素制剂的制备方法及伊维菌素制剂 |
CN109394713A (zh) * | 2018-12-26 | 2019-03-01 | 湖北中博绿亚生物技术有限公司 | 复方芬苯达唑噻嘧啶及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105287613B (zh) | 2019-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105267230A (zh) | 一种复方芬苯达唑片剂 | |
CN105287613A (zh) | 一种复方芬苯达唑片剂的制备方法 | |
CN100589807C (zh) | 一种复方磺胺间甲氧嘧啶钠注射液的配方及制作工艺 | |
Burke et al. | Herbal dewormer fails to control gastrointestinal nematodes in goats | |
CN101780153B (zh) | 一种猪用中药组合物及其制备方法和应用 | |
Mwale et al. | In vivo anthelmintic efficacy of Aloe ferox, Agave sisalana, and Gunnera perpensa in village chickens naturally infected with Heterakis gallinarum | |
CN101664437B (zh) | 一种治疗球虫病的中药及其制备方法和用途 | |
CN102670694B (zh) | 一种治疗猪伪狂犬病的中药组合物及其制备方法和应用 | |
CN104435023A (zh) | 一种中药提取物及其应用 | |
CN103768157A (zh) | 一种兽用抗病毒中药紫芪泡腾颗粒药物及其制备方法 | |
CN102579622B (zh) | 一种治疗副猪嗜血杆菌病的中草药制剂及其制备方法 | |
CN109394713A (zh) | 复方芬苯达唑噻嘧啶及其制备方法 | |
CN108743923A (zh) | 一种用于畜禽抗病毒提高免疫力的复方制剂及其制备方法 | |
CN101249097B (zh) | 灰树花多糖在制备防治猪病毒性疾病药物中的应用 | |
CN113679681A (zh) | 复方芬苯达唑片剂及其制备方法 | |
CN106539754A (zh) | 氢溴酸常山酮溶液及其制备方法 | |
CN103784685B (zh) | 治疗畜禽病毒性传染病的中药组合物及其制备方法和应用 | |
CN1634364A (zh) | 一种用于治疗盆腔炎症等疾病的灌肠剂 | |
CN105381024A (zh) | 一种用于治疗鸡球虫病的药物组合物及其制备方法 | |
CN109498701A (zh) | 一种防治鹅副粘病毒的中药组合物及其制备方法和应用 | |
CN105878875A (zh) | 一种用于防治禽坏死性肠炎的中药超微粉颗粒剂及其制备方法 | |
CN1299684C (zh) | 水产动物抗菌药及其制备方法 | |
CN116036188B (zh) | 防治鸡球虫病的中药组合物及其制备方法与应用 | |
CN109172650A (zh) | 一种防治小鹅瘟的中药组合物及其制备方法和应用 | |
CN107320671B (zh) | 一种杀虫中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190409 Termination date: 20211012 |
|
RR01 | Reinstatement of patent right | ||
RR01 | Reinstatement of patent right |
Former decision: Termination of patent rights for unpaid annual fees Former decision publication date: 20220920 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240117 Address after: Building 6, Building 304A, Blue Biomedical Industry Park, No. 368 Hedong Road, High tech Zone, Qingdao, Shandong Province, 266109 Patentee after: Qingdao Deji Agricultural Biotechnology Co.,Ltd. Address before: No. 700 Changcheng Road, Chengyang District, Qingdao City, Shandong Province, 266061 Patentee before: Qingdao Agricultural University |